Related Experiment Video
Updated: May 10, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades
Yi-Chao Shi1, Hong Zhao, Chuan Yin
1Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Background And Aims:
CCAAT/enhancer binding protein α is one of the key transcription factors of the hepatocyte nuclear factors family, which plays a critical role in liver cell proliferation and differentiation. However, the role of CCAAT/enhancer binding protein α in hepatocarcinogenesis remains to be defined.
Methods:
A recombinant adenovirus carrying the C/EBPα gene was constructed to determine its effect on hepatocarcinogenesis in vitro and in vivo.
Results:
We demonstrated that overexpression of CCAAT/enhancer binding protein α inhibited the tumourigenicity of Huh7 cells, re-established the expression of certain liver-specific genes and induced G0/G1 arrest. Overexpression of CCAAT/enhancer binding protein α significantly suppressed the proliferation of primary hepatocarcinogenesis cells and tumour associated fibroblasts in vitro. Additionally, intratumoural injection of adenovirus carrying the C/EBPα reduced the growth of subcutaneous hepatocarcinogenesis xenografts in nude mice. Systemic administration of adenovirus carrying the C/EBPα resulted in the eradication of orthotopic liver hepatocarcinogenesis nodules in nude mice. Further, up-regulation of CCAAT/enhancer binding protein α reduced the expression of Notch3, thereby suppressing Hes1 transactivation activity and leading to decreased p27 expression. Overexpression of Hes1 partially abolished the anti-proliferation effect of CCAAT/enhancer binding protein α on Huh7 cells.
Conclusion:
These results suggested that the effect of CCAAT/enhancer binding protein α on hepatocarcinogenesis is partially through by reducing Notch3/Hes1/p27 cascades and CCAAT/enhancer binding protein α may possess a novel therapeutic potential for human hepatocarcinogenesis.
Insights
CCAAT/enhancer binding protein α (C/EBPα) inhibits liver cancer growth by reducing tumor cell proliferation and re-establishing liver-specific gene expression. C/EBPα shows therapeutic potential for hepatocarcinogenesis by targeting the Notch3/Hes1/p27 pathway.
Area of Science:
- Hepatology
- Molecular Biology
- Cancer Research
Background:
- CCAAT/enhancer binding protein α (C/EBPα) is a key transcription factor in liver cell function.
- The role of C/EBPα in hepatocarcinogenesis is not fully understood.
Purpose of the Study:
- To investigate the role of C/EBPα in hepatocarcinogenesis.
- To determine the therapeutic potential of C/EBPα in liver cancer.
Main Methods:
- Constructed a recombinant adenovirus carrying the C/EBPα gene.
- Assessed the effects of C/EBPα on hepatocarcinogenesis in vitro and in vivo models.
Main Results:
- Overexpression of C/EBPα inhibited tumor cell growth, re-established liver-specific gene expression, and induced cell cycle arrest.
- C/EBPα suppressed proliferation of cancer cells and fibroblasts, reduced tumor xenograft growth, and eradicated orthotopic liver tumors.
- C/EBPα reduced Notch3 expression, suppressing Hes1 activity and decreasing p27 levels, partially reversing the anti-proliferation effects.
Conclusions:
- C/EBPα exerts its anti-hepatocarcinogenesis effects partly via the Notch3/Hes1/p27 pathway.
- C/EBPα demonstrates significant therapeutic potential for human hepatocarcinogenesis.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
07:26Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Cell Specific Gene Expression
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway